Diagnosis and treatment of peripartum cardiomyopathy: a case report
https://doi.org/10.34215/1609-1175-2026-2-70-74
Abstract
Peripartum cardiomyopathy (PPCM) is a rare heart muscle disease that affects women during the last month of pregnancy or within five months after childbirth. The disease manifests as acute and/or chronic heart failure (CHF). In addition to standard CHF therapy, PPCM treatment includes bromocriptine, which blocks the production of anti-angiogenic 16kDa low-molecular-weight prolactin. This prolactin plays an important role in PPCM pathogenesis. Although effective treatments are available, some aspects of managing this condition remain unresolved, ranging from epidemiology to treatment duration. This article presents a clinical case report of a patient with PCMP and details the monitoring of her clinical, instrumental, and laboratory data over a 15-month period.
About the Authors
D. Yu. Bogdanov
Vladivostok Clinical Hospital № 1; Pacific State Medical University
Russian Federation
Russian Federation
Dmitry Yu. Bogdanov - Head of the Cardiology Department, Vladivostok CH No. 1; Associate Professor, Institute of Therapy and Instrumental Diagnostics, Pacific SMU.
2 Ostryakova ave., Vladivostok, 690002
V. A. Nevzorova
Pacific State Medical University
Russian Federation
Russian Federation
Vladivostok
E. A. Kondrashova
Vladivostok Clinical Hospital № 1; Pacific State Medical University
Russian Federation
Russian Federation
Vladivostok
T. V. Lubchenko
Vladivostok Clinical Hospital № 1
Russian Federation
Russian Federation
Vladivostok
References
1. Clinical Guidelines for Dilated Cardiomyopathy. Ministry of Health of Russia. Moscow. 2025. (In Russ.) URL: https://www.cardioc.ru/spetsialistam/klinicheskie-rekomendatsii/25/Дилатационная_кардиомиопатия_(2025).pdf (Accessed Mar 14, 2026).
2. De Backer J, Haugaa KH, Hasselberg NE, de Hosson M, Brida M, Castelletti S et al.; ESC Scientific Document Group. 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy. Eur Heart J. 2025;46(43):4462–568. doi: 10.1093/eurheartj/ehaf193
3. Hosseinpour A, Hosseinpour H, Kheshti F, Abdollahifard S, Attar A. Prognostic value of various markers in recovery from peripartum cardiomyopathy: a systematic review and meta-analysis. ESC Heart Fail. 2022;9(5):3483–95. doi: 10.1002/ehf2.14085
4. Prameswari HS, Kamarullah W, Pranata R, Putra ICS, Undarsa AC, Iqbal M et al. Meta-analysis of cardiac magnetic resonance in prognosticating left ventricular function in peripartum cardiomyopathy. ESC Heart Fail. 2025;12(1):304–15. doi: 10.1002/ehf2.15024
5. Kumar A, Ravi R, Sivakumar RK, Chidambaram V, Majella MG, Sinha S et al. Prolactin Inhibition in Peripartum Cardiomyopathy: Systematic Review and Meta-analysis. Curr Probl Cardiol. 2023;48(2):101461. doi: 10.1016/j.cpcardiol.2022.101461
6. Sliwa K, Hilfiker-Kleiner D, Damasceno A, Al Farhan H, Goland S, Johnson MR et al. Peripartum cardiomyopathy. Lancet. 2025;406(10518):2483–93. doi: 10.1016/S0140-6736(25)01451-5
7. Barasa A, Rosengren A, Sandström TZ, Ladfors L, Schaufelberger M. Heart Failure in Late Pregnancy and Postpartum: Incidence and Long-Term Mortality in Sweden From 1997 to 2010. J Card Fail. 2017;23(5):370–8. doi: 10.1016/j.cardfail.2016.12.011
8. Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, BarrialesVilla R, Basso C et al.; ESC Scientific Document Group. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44(37):3503–626. doi: 10.1093/eurheartj/ehad194
9. Sliwa K, Petrie MC, van der Meer P, Mebazaa A, Hilfiker-Kleiner D, Jackson AM et al. Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry. Eur Heart J. 2020;41(39):378797. doi: 10.1093/eurheartj/ehaa455
10. Iannaccone G, Graziani F, Kacar P, Tamborrino PP, Lillo R, Montanaro C et al. Diagnosis and management of peripartum cardiomyopathy and recurrence risk. Int J Cardiol Congenit Heart Dis. 2024;17:100530. doi: 10.1016/j.ijcchd.2024.100530
Review
For citations:
Bogdanov D.Yu., Nevzorova V.A., Kondrashova E.A., Lubchenko T.V. Diagnosis and treatment of peripartum cardiomyopathy: a case report. Pacific Medical Journal. 2026;(2):70-74. (In Russ.) https://doi.org/10.34215/1609-1175-2026-2-70-74
Views:
51
JATS XML
Email this article 